Integrating Reinforcement Learning and Monte Carlo Tree Search for enhanced neoantigen vaccine design
View abstract on PubMed
Summary
This summary is machine-generated.UltraMutate, a new algorithm, enhances neoantigen vaccine design by finding peptide mutations with stronger binding to human leukocyte antigen (HLA) molecules. This approach improves the potential for robust adaptive immune responses in cancer immunotherapy.
Area Of Science
- Immunology
- Computational Biology
- Bioinformatics
Background
- Cancer immunotherapy shows promise with neoantigen vaccines.
- Weak peptide-HLA binding affinity can limit vaccine efficacy and adaptive immune responses.
- Enhancing peptide-HLA binding through mutation is a potential strategy for improved vaccine design.
Purpose Of The Study
- To introduce UltraMutate, a novel algorithm for identifying peptide mutations with enhanced binding affinity to human leukocyte antigen (HLA) molecules.
- To ensure identified mutations retain high homology with the original neoantigen, preserving potential immunogenicity.
- To improve the design of neoantigen-based vaccines for personalized immunotherapy.
Main Methods
- Developed UltraMutate, an algorithm integrating Reinforcement Learning and Monte Carlo Tree Search.
- Utilized peptide-HLA binding affinity and homology metrics for mutation identification.
- Validated UltraMutate's performance on an independent test set of 3660 peptide-HLA pairs.
Main Results
- UltraMutate identified peptide mutations with significantly enhanced binding affinities to target HLA molecules.
- The algorithm successfully preserved high homology between mutated and original neoantigens.
- UltraMutate outperformed existing state-of-the-art methods in identifying affinity-enhancing mutations.
- Demonstrated applicability in designing peptide vaccines for Human Papillomavirus and Human Cytomegalovirus.
Conclusions
- UltraMutate is a powerful tool for designing effective neoantigen-based vaccines.
- The algorithm addresses the challenge of weak peptide-HLA binding in immunotherapy.
- UltraMutate holds significant potential for advancing personalized cancer immunotherapy.
Related Concept Videos
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Overview
Vaccination is the administration of antigenic material from pathogens to confer immunity against a specific microorganism. Vaccination primes the immune system to recognize and mount an immune response faster and more effectively if the real pathogen is encountered. Vaccinations are one of the most efficient ways to protect both individual humans and the general public from disease. A growing anti-vaccination skepticism risks the successes of vaccination programs that helped reduce...
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...

